Stocktoria

Dianthus Therapeutics, Inc. /DE/ DNTH

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-21

Dianthus Therapeutics, Inc. /DE/ statistics & valuation

Market cap$5.2B
P / B10.6×
Net margin-7973.3%
Return on equity-32.9%
Return on capital-35.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1541.20% -1362.80% -7973.30% 201720182019202020212022202320242025
Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
-1704.70% -1633.70% -8739.30% 201720182019202020212022202320242025
Return on equity (%)
-39.50% -54.40% -52.10% -25.80% -24.10% -32.90% 201720182019202020212022202320242025
Shares outstanding
2.4M 33.3M 39.3M 48.5M 58.8M 875279 14.8M 33.3M 43.2M 201720182019202020212022202320242025
Net debt ($)
201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-65.20% -36.60% -47.50% -46.40% -37.50% -34.30% -24.30% -22.70% -30.60% 201720182019202020212022202320242025
Free cash flow margin (%)
201720182019202020212022202320242025
Debt / equity (×)
201720182019202020212022202320242025
EPS ($)
-$1.71 -$1.29 -$32.57 -$8.45 -$2.55 -$4.20 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-8739.3%-1633.7%-1704.7%——————
Net margin-7973.3%-1362.8%-1541.2%——————
Return on assets-30.6%-22.7%-24.3%-34.3%-37.5%-46.4%-47.5%-36.6%-65.2%
Return on equity-32.9%-24.1%-25.8%64.2%412.4%-52.1%-54.4%-39.5%84.3%
Current ratio13.3215.2218.429.9716.6313.2610.6213.9512.68

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.